Hoth Therapeutics Stock Shares Outstanding

HOTH Stock  USD 1.20  0.02  1.64%   
Hoth Therapeutics fundamentals help investors to digest information that contributes to Hoth Therapeutics' financial success or failures. It also enables traders to predict the movement of Hoth Stock. The fundamental analysis module provides a way to measure Hoth Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hoth Therapeutics stock.
The current Common Stock Shares Outstanding is estimated to decrease to about 1.8 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Hoth Therapeutics Company Shares Outstanding Analysis

Hoth Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Hoth Therapeutics Shares Outstanding

    
  4.89 M  
Most of Hoth Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hoth Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Hoth Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Hoth Therapeutics is extremely important. It helps to project a fair market value of Hoth Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Hoth Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Hoth Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Hoth Therapeutics' interrelated accounts and indicators.
1.00.92-0.93-0.880.440.90.821.01.01.00.54-0.810.350.06-0.6-0.41-0.41
1.00.9-0.92-0.860.370.880.761.00.991.00.56-0.780.380.08-0.56-0.41-0.41
0.920.9-0.99-0.990.390.940.830.90.920.910.24-0.750.08-0.25-0.84-0.68-0.68
-0.93-0.92-0.990.96-0.32-0.89-0.78-0.92-0.94-0.93-0.290.7-0.150.240.790.680.68
-0.88-0.86-0.990.96-0.41-0.94-0.84-0.86-0.89-0.87-0.150.80.030.330.890.690.69
0.440.370.39-0.32-0.410.440.80.370.440.380.24-0.630.040.04-0.30.220.22
0.90.880.94-0.89-0.940.440.840.880.890.880.36-0.90.16-0.06-0.73-0.6-0.6
0.820.760.83-0.78-0.840.80.840.760.820.770.29-0.840.08-0.07-0.68-0.27-0.27
1.01.00.9-0.92-0.860.370.880.760.991.00.56-0.780.380.08-0.56-0.41-0.41
1.00.990.92-0.94-0.890.440.890.820.991.00.52-0.810.330.04-0.61-0.41-0.41
1.01.00.91-0.93-0.870.380.880.771.01.00.54-0.780.360.07-0.58-0.42-0.42
0.540.560.24-0.29-0.150.240.360.290.560.520.54-0.460.950.790.320.170.17
-0.81-0.78-0.750.70.8-0.63-0.9-0.84-0.78-0.81-0.78-0.46-0.22-0.080.530.310.31
0.350.380.08-0.150.030.040.160.080.380.330.360.95-0.220.80.470.160.16
0.060.08-0.250.240.330.04-0.06-0.070.080.040.070.79-0.080.80.680.550.55
-0.6-0.56-0.840.790.89-0.3-0.73-0.68-0.56-0.61-0.580.320.530.470.680.740.74
-0.41-0.41-0.680.680.690.22-0.6-0.27-0.41-0.41-0.420.170.310.160.550.741.0
-0.41-0.41-0.680.680.690.22-0.6-0.27-0.41-0.41-0.420.170.310.160.550.741.0
Click cells to compare fundamentals

Hoth Shares Outstanding Historical Pattern

Today, most investors in Hoth Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Hoth Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Hoth Therapeutics shares outstanding as a starting point in their analysis.
   Hoth Therapeutics Shares Outstanding   
       Timeline  
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Hoth Common Stock Shares Outstanding

Common Stock Shares Outstanding

1.85 Million

As of now, Hoth Therapeutics' Common Stock Shares Outstanding is decreasing as compared to previous years.
Based on the latest financial disclosure, Hoth Therapeutics has 4.89 M of shares currently outstending. This is 97.29% lower than that of the Pharmaceuticals sector and 95.42% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.15% higher than that of the company.

Hoth Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hoth Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hoth Therapeutics could also be used in its relative valuation, which is a method of valuing Hoth Therapeutics by comparing valuation metrics of similar companies.
Hoth Therapeutics is currently under evaluation in shares outstanding category among related companies.

Hoth Therapeutics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Hoth Therapeutics from analyzing Hoth Therapeutics' financial statements. These drivers represent accounts that assess Hoth Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Hoth Therapeutics' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap56.7M29.3M14.7M9.3M4.9M4.7M
Enterprise Value55.0M26.7M6.2M2.9M(4.3M)(4.1M)

Hoth Fundamentals

About Hoth Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Hoth Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hoth Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hoth Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hoth Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hoth Therapeutics' short interest history, or implied volatility extrapolated from Hoth Therapeutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out Hoth Therapeutics Piotroski F Score and Hoth Therapeutics Altman Z Score analysis.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
FinTech Suite
Use AI to screen and filter profitable investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.30)
Return On Assets
(0.59)
Return On Equity
(1.13)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.